909 related articles for article (PubMed ID: 18260992)
1. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
[TBL] [Abstract][Full Text] [Related]
2. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic role of extremely high levels of the B-type natriuretic prohormone with regard to the in-hospital mortality of patients hospitalized for heart failure].
Bózsik B; Nagy E; Somlói M; Tomcsányi J
Orv Hetil; 2017 May; 158(20):779-782. PubMed ID: 28502208
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
5. [Heart-type fatty acid binding protein for the assessment of the short-term prognosis in acute pulmonary embolism patients with hemodynamic stability on admission].
Chen Y; Liu S; Guo W; Wang ZZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):516-21. PubMed ID: 24262088
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure].
Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of combination of NT-proBNP with high sensitive cTn I in patients with heart failure: Results from retrospective study in an emergency department.
Cheng H; Fan WZ; Wang SC; Geng J; Zang HL; Shen XH; Liu ZH; Wang LZ
Scand J Clin Lab Invest; 2016 Sep; 76(5):361-7. PubMed ID: 27228479
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
[TBL] [Abstract][Full Text] [Related]
10. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
Bettencourt P; Azevedo A; Pimenta J; Friões F; Ferreira S; Ferreira A
Circulation; 2004 Oct; 110(15):2168-74. PubMed ID: 15451800
[TBL] [Abstract][Full Text] [Related]
11. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
12. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
[TBL] [Abstract][Full Text] [Related]
13. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
Naruse H; Ishii J; Takahashi H; Kitagawa F; Nishimura H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Hayashi M; Sarai M; Watanabe E; Izawa H; Ozaki Y
Crit Care; 2018 Aug; 22(1):197. PubMed ID: 30119691
[TBL] [Abstract][Full Text] [Related]
14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
15. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
[TBL] [Abstract][Full Text] [Related]
16. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
17. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of analysis of H-FABP, NT-proBNP, and cTnI in heart function in children with congenital heart disease and pneumonia.
Zhou FJ; Zhou CY; Tian YJ; Xiao AJ; Li PL; Wang YH; Jia JW
Eur Rev Med Pharmacol Sci; 2014; 18(10):1513-6. PubMed ID: 24899611
[TBL] [Abstract][Full Text] [Related]
19. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
20. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
